Viewing Study NCT03297593


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-01-05 @ 6:35 PM
Study NCT ID: NCT03297593
Status: COMPLETED
Last Update Posted: 2025-06-06
First Post: 2017-09-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
Sponsor: Swiss Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module